IgA represents the initial defense that the body offers against invading pathogens and dysbiosis (195) and studies have associated IgA producing cells with microbiota composition and metabolic effects (117, 118), future research should characterize the role of IgA in obesity metabolic disease in more detail. This evidence concerns the gene CD79A and obesity due to melanocortin 4 receptor deficiency.